Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Susanne Kruger Kjaer, Danish Cancer Society Identifier:
First received: June 30, 2009
Last updated: August 7, 2015
Last verified: August 2015
The purpose of this study is to determine the prevalence and type distribution of genital human papillomavirus (HPV) infection in Tanzanian men.

Human Papillomavirus Infection

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence and Type Distribution of Genital Human Papillomavirus (HPV) in Tanzanian Men

Resource links provided by NLM:

Further study details as provided by Danish Cancer Society:

Primary Outcome Measures:
  • HPV infection [ Time Frame: At enrollment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • HIV infection [ Time Frame: At enrollment ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
cell scrapes from penis

Enrollment: 1933
Study Start Date: March 2009
Study Completion Date: December 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Human papillomavirus
Tanzanian men with HPV and Tanzanian men without

  Show Detailed Description


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Tanzanian men from an urban setting (Dar es Sallam)(factories, University, college)and men from an rural setting (Muhesa, Mwanga, Bagamoyo)

Inclusion Criteria:

  • men who are able to understand the information about the study (in writing or oral)

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00932009

Inst. of Cancer Epidemiology, Danish Cancer Society
Copenhagen, Denmark, DK-2100
Sponsors and Collaborators
Danish Cancer Society
Merck Sharp & Dohme Corp.
Principal Investigator: Susanne K. Kjaer, Professor MD Inst. of Cancer Epidemiology,Danish Cancer Society
  More Information

No publications provided by Danish Cancer Society

Additional publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Susanne Kruger Kjaer, Professor, Danish Cancer Society Identifier: NCT00932009     History of Changes
Other Study ID Numbers: HPV IISP #36113
Study First Received: June 30, 2009
Last Updated: August 7, 2015
Health Authority: Tanzania: Ministry of Health
Tanzania: National Institute for Medical Research

Keywords provided by Danish Cancer Society:
Human papillomavirus infection
Tanzanian men

Additional relevant MeSH terms:
Papillomavirus Infections
DNA Virus Infections
Tumor Virus Infections
Virus Diseases processed this record on November 30, 2015